- Sep 21, 2016
- 1,051
- Tinnitus Since
- 2011 - T, 2016- H, relapsed 2019
- Cause of Tinnitus
- noise-induced
I think you would get the real drug.If Compassionate Use was granted for FX-322, would they still give you placebo or give you the real drug?
I think you would get the real drug.If Compassionate Use was granted for FX-322, would they still give you placebo or give you the real drug?
You get stabbed in the face for that where I grew up.
They only give you placebo for compassionate use if you stay in room 1408.If Compassionate Use was granted for FX-322, would they still give you placebo or give you the real drug?
For compassionate use I'll stay in room 1408, heck I'll stay room 14008 for a whole month.They only give you placebo for compassionate use if you stay in room 1408.
There are many of us here who would chop our own limbs off just to get a chance to take these drugs.For compassionate use I'll stay in room 1408, heck I'll stay room 14008 for a whole month.
It is a lot easier to get redosing and reformulation done after a medicine has been approved and released because the criteria is a lot less stringent. A few techniques are also being researched now like cochlear pumping which has been shown to be very effective at getting medicine deep in the ear. Essentially if Frequency Therapeutics cannot get FX-322 working well with the lower frequencies then I certainly see them looking into a redosing with a technique like this.Regarding delivery - This seems to be the main hurdle for Frequency Therapeutics to improve on at the moment, correct? Sure, there might be other reasons why FX-322 is working "better" in a lab setting than in humans, but surely there's a good chance that results will improve if the delivery method is improved.
I remember Carl LeBel saying something in the Tinnitus Talk Podcast about them looking heavily into different delivery methods. I haven't read or heard much about this elsewhere though. Is there any more info out there on their approach on this? What other delivery methods are they potentially exploring? Could it be anything else than injections, and/or can the type of gel and/or type of injection be improved somehow? Could this be something they can improve on in Phase 3 for example, or would they have to restart at a Phase 1?
Sorry, just blaring out questions here in hopes someone has a clue...
I don't think anyone can answer that question for you.If I were to participate and get the medicine, what do you think my gains would be?
Hard to tell. It depends on how much cumulative damage you've got over the years. I know for a fact I have cumulative damage from listening to loud music but it doesn't show up on an audiogram.If I were to participate and get the medicine, what do you think my gains would be?
This. I think this is why Frequency Therapeutics is aiming to get FX-322 approved now with the four doses and is going to look at things like the benefit of more injections or new dosing methods later on when it is inevitably much simpler to do too.Hard to tell. It depends on how much cumulative damage you've got over the years. I know for a fact I have cumulative damage from listening to loud music but it doesn't show up on an audiogram.
Me too. I actually laughed picturing a pinhead type figure presiding over "compassionate use." Pure dark comedy gold.Wouldn't it be hilarious to be given a drug under 'compassionate use' and be told on your death bed that it was actually a placebo? Like 'Is this some strange use of the word compassion with which I was previously unfamiliar?' Sorry, I thought it was funny in a black kind of way. Moving right along,..
Eventually we will have that answer but the hard numbers are what these trials are trying to work out.If I were to participate and get the medicine, what do you think my gains would be?
It's possible we both are...Thank goodness. I was worried that I was a bit weird.
1. No idea.Hi Everyone. Long time listener, first time caller. To begin, I'd just like to say that I am very grateful to everyone on this forum sharing their hopes, fears and general information. It's been a great source of relief to me over the years… optimistic and pessimistic alike.
A few lingering questions I've had:
- Does it seem that the folks who were treated with a single dose in the first trial would have most of their hearing restored near 20 kHz and then descending in value until it reached their previously confirmed responses in the middle range? Perhaps their extended audio grams would have "U" shape?
- Not to bring up a sore spot… but FGG mentioned that this drug caused cancer in rats when taken in large doses orally. Is there a good reason to believe it won't do the same when injected in our ears? Apologies if this has been covered.
- My tinnitus took years to develop after confirmed hearing loss. I think it's possible that if the hearing is restored, it will take at least that long for the brain to adapt and lose the ringing. So maybe don't get worried when a recent trial participant doesn't notice a tinnitus change right away.
1. I am not sure what you mean or what you are asking. Are you saying, they got better response at 20 kHz and then less response until 8 kHz?Hi Everyone. Long time listener, first time caller. To begin, I'd just like to say that I am very grateful to everyone on this forum sharing their hopes, fears and general information. It's been a great source of relief to me over the years… optimistic and pessimistic alike.
A few lingering questions I've had:
- Does it seem that the folks who were treated with a single dose in the first trial would have most of their hearing restored near 20 kHz and then descending in value until it reached their previously confirmed responses in the middle range? Perhaps their extended audio grams would have "U" shape?
- Not to bring up a sore spot… but FGG mentioned that this drug caused cancer in rats when taken in large doses orally. Is there a good reason to believe it won't do the same when injected in our ears? Apologies if this has been covered.
- My tinnitus took years to develop after confirmed hearing loss. I think it's possible that if the hearing is restored, it will take at least that long for the brain to adapt and lose the ringing. So maybe don't get worried when a recent trial participant doesn't notice a tinnitus change right away.
I can't really answer your other questions, but I have researched this one so I'll take a stab at answering it.A few lingering questions I've had:
- Does it seem that the folks who were treated with a single dose in the first trial would have most of their hearing restored near 20 kHz and then descending in value until it reached their previously confirmed responses in the middle range? Perhaps their extended audio grams would have "U" shape?
But hasn't it been shown that FX-322 also regrows synapse connections to the hair cell once the hair cell is regrown?The thing is though that the approval and availability of a synapse medicine is going to provide individuals with a lot of benefit since it is incredibly likely that most people have a mix of hair cell and synapse issues which won't get treated with a single medicine.
Just like calling 40 dB hearing loss "mild" and only testing people's hearing up to 8 kHz and saying they have no hearing loss.Statistic rules get followed with clinical trials because this is a point of accuracy in results. Really the reality is even if something is or is not statistically significant, it does not have a bearing on whether somebody notices a gain or not. Now looking at the first FX-322 trial there tended to be some who claimed that the 10-15 dB improvement and/or the word recognition improvement is nothing fancy or significant, yet in reality those who benefited got real gains from the treatment and actually would have noticed this personally. This is why statistical analysis of certain things can be somewhat flawed and not representative of the actual benefits and improvements something can have on somebody.
Yes but if you have synaptopathy without a corresponding hair cell loss, then you'll a need synapse drug too.But hasn't it been shown that FX-322 also regrows synapse connections to the hair cell once the hair cell is regrown?
Just like calling 40 dB hearing loss "mild" and only testing people's hearing up to 8 kHz and saying they have no hearing loss.
There can be. Unfortunately, there isn't a great diagnostic test for it. A lot of people will just have to trial treat with both drugs.Does anyone know if there is synapse damage with sudden hearing loss?
From what has been described by Frequency Therapeutics, there is a progenitor "support" cell for each Inner and Outer hair cell lining the cochlea. Frequency Therapeutics has described patients returning for repeat dosages; so I don't see the benefit in waiting until you get to a certain level.I have a question regarding progenitor cells. Do we have one per hair cell or how does it work?
Unfortunately hearing loss and tinnitus runs in my family so I'll probably lose more hearing as I age. If we end up with a launch of FX-322, would it be wise to wait until I'm older if my hearing and tinnitus doesn't get worse or do we have the possibility to take it multiple times?
I can live with my tinnitus and hyperacusis for now but of course I would wish to get rid of it sooner than later
You can see some nice diagrams here:I have a question regarding progenitor cells. Do we have one per hair cell or how does it work?
You'll be able to take it multiple times, it doesn't deplete the support cells. In fact, in one of their investor conferences they talked about the possibility of people getting a "booster" shot once a year.Unfortunately hearing loss and tinnitus runs in my family so I'll probably lose more hearing as I age. If we end up with a launch of FX-322, would it be wise to wait until I'm older if my hearing and tinnitus doesn't get worse or do we have the possibility to take it multiple times?
I can live with my tinnitus and hyperacusis for now but of course I would wish to get rid of it sooner than later
Well, investors love booster shots (repeat customers)You'll be able to take it multiple times, it doesn't deplete the support cells. In fact, in one of their investor conferences they talked about the possibility of people getting a "booster" shot once a year.